Payment overview · 2025
General Payments
1 reported records · 1 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Family Medicine · SPARTANBURG, SC · NPI 1861460883
Verified facts
CMS Open Payments records show Stephanie Phillips, MD received $16.00 in general payments during 2025 across 1 reported records.
Biogen, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
1 reported records · 1 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Biogen, Inc. | Unresolved — no canonical attribution shown | $16.00 | 100.0% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $16.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| TYSABRI Normalized: tysabri |
Biological | Biogen, Inc. | $16.00 | 1 | 2025 |
Source payment records
|
|||||
| VUMERITY Normalized: vumerity |
Drug | Biogen, Inc. | $16.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 609 | 186 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 602 | 199 |
| Amlodipine Besylate | Amlodipine Besylate | 518 | 170 |
| Losartan Potassium | Losartan Potassium | 492 | 156 |
| Levothyroxine Sodium | Levothyroxine Sodium | 422 | 117 |
| Omeprazole | Omeprazole | 350 | 117 |
| Lisinopril | Lisinopril | 312 | 99 |
| Gabapentin | Gabapentin | 296 | 116 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 248 | 79 |
| Trazodone Hcl | Trazodone Hcl | 228 | 72 |
| Lorazepam | Lorazepam | 210 | 45 |
| Pantoprazole Sodium | Pantoprazole Sodium | 203 | 64 |
| Metoprolol Succinate | Metoprolol Succinate | 183 | 59 |
| Escitalopram Oxalate | Escitalopram Oxalate | 179 | 55 |
| Hydrochlorothiazide | Hydrochlorothiazide | 156 | 57 |
| Metformin Hcl Er | Metformin Hcl | 155 | 51 |
| Potassium Chloride | Potassium Chloride | 153 | 51 |
| Carvedilol | Carvedilol | 148 | 47 |
| Furosemide | Furosemide | 147 | 53 |
| Metformin Hcl | Metformin Hcl | 147 | 49 |
| Tamsulosin Hcl | Tamsulosin Hcl | 144 | 53 |
| Sertraline Hcl | Sertraline Hcl | 137 | 38 |
| Jardiance | Empagliflozin | 129 | 39 |
| Tramadol Hcl | Tramadol Hcl | 125 | 41 |
| Tizanidine Hcl | Tizanidine Hcl | 123 | 55 |
| Duloxetine Hcl | Duloxetine Hcl | 115 | 29 |
| Zolpidem Tartrate | Zolpidem Tartrate | 110 | 25 |
| Famotidine | Famotidine | 106 | 38 |
| Metoprolol Tartrate | Metoprolol Tartrate | 106 | 35 |
| Simvastatin | Simvastatin | 104 | 32 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 102 | 27 |
| Fluticasone Propionate | Fluticasone Propionate | 100 | 48 |
| Ozempic | Semaglutide | 100 | 25 |
| Eliquis | Apixaban | 97 | 30 |
| Bupropion Xl | Bupropion Hcl | 96 | 33 |
| Clonazepam | Clonazepam | 96 | 21 |
| Prednisone | Prednisone | 95 | 81 |
| Azelastine Hcl | Azelastine Hcl | 93 | 40 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 93 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 91 | 27 |
| Alendronate Sodium | Alendronate Sodium | 89 | 34 |
| Pravastatin Sodium | Pravastatin Sodium | 88 | 25 |
| Montelukast Sodium | Montelukast Sodium | 87 | 27 |
| Mirtazapine | Mirtazapine | 86 | 24 |
| Meloxicam | Meloxicam | 79 | 31 |
| Alprazolam | Alprazolam | 76 | 20 |
| Allopurinol | Allopurinol | 75 | 25 |
| Tresiba Flextouch U-100 | Insulin Degludec | 75 | 20 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 73 | 26 |
| Temazepam | Temazepam | 73 | 15 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 68 | 19 |
| Ondansetron Hcl | Ondansetron Hcl | 68 | 38 |
| Spironolactone | Spironolactone | 66 | 26 |
| Fluoxetine Hcl | Fluoxetine Hcl | 65 | 17 |
| Azithromycin | Azithromycin | 62 | 58 |
| Buspirone Hcl | Buspirone Hcl | 62 | 19 |
| Celecoxib | Celecoxib | 62 | 28 |
| Ezetimibe | Ezetimibe | 60 | 20 |
| Fluconazole | Fluconazole | 60 | 30 |
| Glipizide Er | Glipizide | 60 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 59 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 57 | 18 |
| Ropinirole Hcl | Ropinirole Hcl | 56 | 16 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 55 | 20 |
| Breo Ellipta | Fluticasone/Vilanterol | 53 | 16 |
| Cephalexin | Cephalexin | 51 | 40 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 51 | 40 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 51 | 20 |
| Topiramate | Topiramate | 50 | 21 |
| Warfarin Sodium | Warfarin Sodium | 50 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 49 | 14 |
| Valsartan | Valsartan | 49 | 15 |
| Donepezil Hcl | Donepezil Hcl | 47 | 17 |
| Diclofenac Sodium | Diclofenac Sodium | 46 | 18 |
| Pregabalin | Pregabalin | 46 | 16 |
| Citalopram Hbr | Citalopram Hydrobromide | 45 | 14 |
| Glipizide | Glipizide | 45 | 13 |
| Memantine Hcl | Memantine Hcl | 45 | 17 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 41 | suppressed |
| Atenolol | Atenolol | 39 | 12 |
| Droplet Pen Needle | Pen Needle, Diabetic | 37 | 13 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 37 | 20 |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 36 | 15 |
| Hydralazine Hcl | Hydralazine Hcl | 36 | 11 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 35 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 34 | 12 |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 34 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 32 |
| Fenofibrate | Fenofibrate | 33 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 33 | 11 |
| Linzess | Linaclotide | 33 | 12 |
| Meclizine Hcl | Meclizine Hcl | 33 | 19 |
| Estradiol | Estradiol | 32 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 32 | 25 |
| Prazosin Hcl | Prazosin Hcl | 31 | suppressed |
| Aripiprazole | Aripiprazole | 30 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 27 | suppressed |
| Hydrocortisone | Hydrocortisone | 27 | suppressed |
| Mounjaro | Tirzepatide | 27 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 26 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 26 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 23 | suppressed |
| Irbesartan | Irbesartan | 23 | suppressed |
| Ibuprofen | Ibuprofen | 22 | suppressed |
| Nitroglycerin | Nitroglycerin | 22 | suppressed |
| Acyclovir | Acyclovir | 21 | suppressed |
| Finasteride | Finasteride | 21 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 21 | suppressed |
| Varenicline Tartrate | Varenicline Tartrate | 21 | suppressed |
| Chlorthalidone | Chlorthalidone | 20 | suppressed |
| Cefdinir | Cefdinir | 19 | 19 |
| Dutasteride | Dutasteride | 19 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 19 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 19 | suppressed |
| Amoxicillin | Amoxicillin | 18 | 18 |
| Januvia | Sitagliptin Phosphate | 18 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 18 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 18 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 18 | suppressed |
| Xarelto | Rivaroxaban | 18 | suppressed |
| Baclofen | Baclofen | 17 | suppressed |
| Methocarbamol | Methocarbamol | 17 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 16 | suppressed |
| Lovastatin | Lovastatin | 16 | suppressed |
| Ondansetron Odt | Ondansetron | 16 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 16 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 16 | 13 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 15 | suppressed |
| Desloratadine | Desloratadine | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 15 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 14 | suppressed |
| Indapamide | Indapamide | 14 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 14 | suppressed |
| Nifedipine Er | Nifedipine | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 14 | suppressed |
| Sucralfate | Sucralfate | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 13 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 13 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 13 | suppressed |
| Nystatin | Nystatin | 13 | 12 |
| Olanzapine | Olanzapine | 13 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 13 | 13 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | 12 |
| Ibu | Ibuprofen | 12 | suppressed |
| Lidocaine Hcl Viscous | Lidocaine Hcl | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Novolog Mix 70-30 Flexpen | Insulin Aspart Prot/Insuln Asp | 12 | suppressed |
| Belsomra | Suvorexant | 11 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 11 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $16.00 · 1 records | Biogen, Inc. | TYSABRI, VUMERITY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error